Non-profit website: free to use. No fees from patients, hospitals or doctors. Not an agency. · Free · Not an agencyLearn more
Radiology & imaging · Peking University First Hospital · Beijing

Dr. Kang Lei康磊

Chief Physician · Professor

Summary compiled from public information, updated 18 Nov 2026. It has not been checked against the hospital website yet. Confirm details with the hospital before you travel.

Dr. Kang Lei

Professional overview

A Chief Physician and Professor specializing in nuclear medicine at Peking University First Hospital, with expertise in radioactive iodine-131 therapy for hyperthyroidism and thyroid cancer, strontium-89 and radium-223 therapy for bone metastases, thyroid disorders, and PET/CT consultation.

SpecialtyRadiology & imaging
Clinical titleChief Physician
Academic rolesProfessor, Doctoral Supervisor, Postdoctoral Supervisor
DepartmentDepartment of Nuclear Medicine
HospitalPeking University First Hospital
CityBeijing
Hospital roleDirector of the Department of Nuclear Medicine, Peking University First Hospital; Party Branch Secretary

Areas of focus

Radioactive iodine-131 therapyfor hyperthyroidism and thyroid cancer
Strontium-89 and radium-223 therapyfor bone metastases
PET/CT consultationin nuclear medicine

Experience & recognition

  • PhD in Imaging and Nuclear Medicine
  • Recipient of Beijing Natural Science Foundation Outstanding Youth Award
  • Recipient of Beijing Science and Technology New Star Award
  • Recipient of Xiao Lun Young Scientist Award (Chinese Nuclear Society)
  • Top Poster Award candidate at the 68th Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI)
  • First-place winner of the CMIIT Young Investigator Award at the 2019 SNMMI Annual Meeting (global annual award, one recipient)
  • Recipient of SNMMI Travel Award (2018)
  • First-place winner of the SNMMI English Speech Contest Beijing Division (2018)
  • Author or co-author of nearly 100 SCI papers, including in Journal of Nuclear Medicine and European Journal of Nuclear Medicine and Molecular Imaging
  • Holding 1 U.S. patent and 1 granted Chinese patent

Professional roles

  • Member, Chinese Medical Association (CMA)
  • Member, Clinical Diagnosis Working Group, Nuclear Medicine Physicians Branch, Chinese Medical Doctor Association (CMDA)
  • Member, PET Working Group, Nuclear Medicine Branch, Chinese Medical Association (CMA)
  • Member, Translational Imaging Professional Committee, Nuclear Medicine Branch, Chinese Medical Association (CMA)
  • Member, Solid Target Radionuclide Working Committee, Nuclear Medicine Branch, Chinese Medical Association (CMA)
  • Member, Nuclear Medicine Subgroup, Oncologic Imaging Professional Committee, China Anti-Cancer Association (CACA)
  • Youth Committee Member, Chinese Nuclear Society Nuclear Medicine Branch
  • Youth Committee Member, Nuclear Medicine Branch, Chinese Medical Imaging Technology Research Association

Frequently asked questions

What does Dr. Kang Lei specialize in?

Specializes in iodine-131 therapy for hyperthyroidism and thyroid cancer, strontium-89 and radium-223 therapy for bone metastases, thyroid diseases, and PET/CT consultation.

Which hospital and department is Dr. Kang Lei in?

Department of Nuclear Medicine at Peking University First Hospital

Sources

Dr. Kang Lei has not reviewed this page.